Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

about

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats.

P2860

Q52565808-3F2B1FD3-626F-4F34-9D70-51EFE7E13DD1

P2860

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

Item

http://www.wikidata.org/entity/Q40081746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

@en

type

Item

label

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

@en

prefLabel

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

@en

P1476

Severe refractory CIDP: a case series of 10 patients treated with bortezomib

@en

P2093

Anke Reinacher-Schick

http://www.w3.org/2001/XMLSchema#string

Christiane Schneider-Gold

http://www.w3.org/2001/XMLSchema#string

Ilka Kröger

http://www.w3.org/2001/XMLSchema#string

Min-Suk Yoon

http://www.w3.org/2001/XMLSchema#string

Ralf Gold

http://www.w3.org/2001/XMLSchema#string

P2860

A critical role for ABCG1 in macrophage inflammation and lung homeostasis.

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.

Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone.

Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.

Practical considerations on the use of rituximab in autoimmune neurological disorders

Humoral immunity and long-lived plasma cells.

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

P2888

s00415-017-8599-4

P304

2010-2020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-017-8599-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

264

http://www.w3.org/2001/XMLSchema#string

P50

Kalliopi Pitarokoili

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28836002

http://www.w3.org/2001/XMLSchema#string

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

about

P2860

P2860

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698